Summary Data for Included Studies.

Note. NZ = New Zealand; IRE = Ireland; NTL = Netherlands; CAN = Canada; FRA = France; SWE = Sweden; IRN = Iran; SWZ = Switzerland; ESP = Spain; DMK = Denmark; EGT = Egypt; SGP = Singapore; JPN = Japan; EST = Estonia; GMY = Germany; AUS = Australia; IBD = inflammatory bowel disorder; TIA = Transient Ischemic Attack; MARS is the Medication Adherence Rating Scale from Thompson, Kulkarni, & Sergejew (2000); MEMS is Medication Event Monitoring System; CQ-R is the Compliance Questionnaire-Rheumatology from de Klerk, van der Heijde, Landewé, van der Tempel, & van der Linden (2003); MMAS is the Morisky Medication Adherence Scale from Morisky, Green, & Levine (1986); TxEQ is the Transplant Effects Questionnaire from Ziegelmann et al. (2002); ACTG is the Adherence to Combination Therapy Guide from Chesney et al., 2000; RAM is the Reported Adherence to Medication Scale from Horne et al., (1999), renamed MARS (Medication Adherence Report Scale); VAS = visual analogue scale.
aAdherence result selected for use in meta-analysis;
bAdherence measure dichotomised into adherent and nonadherent groups;
cRelationship between adherence measure and BMQ scales not reported.

注：NZ即新西兰（New Zealand）；IRE即爱尔兰（Ireland）；NTL即荷兰（Netherlands）；CAN即加拿大（Canada）；FRA即法国（France）；SWE即瑞典（Sweden）；IRN即伊朗（Iran）；SWZ即瑞士（Switzerland）；ESP即西班牙（Spain）；DMK即丹麦（Denmark）；EGT即埃及（Egypt）；SGP即新加坡（Singapore）；JPN即日本（Japan）；EST即爱沙尼亚（Estonia）；GMY即德国（Germany）；AUS即澳大利亚（Australia）；IBD即炎症性肠病（inflammatory bowel disorder）；TIA即短暂性脑缺血发作（Transient Ischemic Attack）；MARS为Thompson、Kulkarni与Sergejew（2000）提出的药物依从性评定量表（Medication Adherence Rating Scale）；MEMS为药物事件监测系统（Medication Event Monitoring System）；CQ-R为de Klerk、van der Heijde、Landewé、van der Tempel及van der Linden（2003）开发的风湿病依从性问卷（Compliance Questionnaire-Rheumatology）；MMAS为Morisky、Green与Levine（1986）提出的Morisky药物依从性量表（Morisky Medication Adherence Scale）；TxEQ为Ziegelmann等人（2002）开发的移植影响问卷（Transplant Effects Questionnaire）；ACTG为Chesney等人（2000）提出的联合治疗依从性指南（Adherence to Combination Therapy Guide）；RAM为Horne等人（1999）提出的药物依从性报告量表（Reported Adherence to Medication Scale），后更名为MARS（药物依从性报告量表，Medication Adherence Report Scale）；VAS即视觉模拟评分法（visual analogue scale）。
a 用于荟萃分析的依从性结果；
b 依从性评估指标被二分为依从组与非依从组；
c 未报告依从性评估指标与BMQ量表之间的关联。